Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress
Fahim Awan
December 23, 2024
The stock performance of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) saw a notable uptick last week. Shares rose 8.14% during the regular session, closing at $3.19,